Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Current protein-based anti-angiogenic therapeutics.
Chakrabarti S, Barrow CJ, Kanwar RK, Ramana V, Kanwar JR. Chakrabarti S, et al. Among authors: ramana v. Mini Rev Med Chem. 2014;14(3):291-312. doi: 10.2174/1389557514666140219114045. Mini Rev Med Chem. 2014. PMID: 24552262 Review.
siRNAs encapsulated in recombinant capsid protein derived from Dengue serotype 2 virus inhibits the four serotypes of the virus and proliferation of cancer cells.
Kumar AS, Reddy GE, Rajmane Y, Nair S, Pai Kamath S, Sreejesh G, Basha K, Chile S, Ray K, Nelly V, Khadpe N, Kasturi R, Ramana V. Kumar AS, et al. Among authors: ramana v. J Biotechnol. 2015 Jan 10;193:23-33. doi: 10.1016/j.jbiotec.2014.11.003. Epub 2014 Nov 11. J Biotechnol. 2015. PMID: 25444872
RelCoVax®, a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice.
Phatarphekar A, Vidyadhar Reddy GEC, Gokhale A, Karanam G, Kuchroo P, Shinde K, Masand G, Pagare S, Khadpe N, Pai SS, Vijayan V, Ramnath RL, Pratap Reddy K, Rao P, Harinarayana Rao S, Ramana V. Phatarphekar A, et al. Among authors: ramana v. Vaccine. 2022 Jul 30;40(32):4522-4530. doi: 10.1016/j.vaccine.2022.06.026. Epub 2022 Jun 13. Vaccine. 2022. PMID: 35718590 Free PMC article.
Safety, immunogenicity and efficacy of Relcovax®, a dual receptor binding domain (RBD) and nucleocapsid (N) subunit protein vaccine candidate against SARS-CoV-2 virus.
Sathe N, Shaikh S, Bhavsar M, Parte L, Gadiparthi A, Kad S, Sensarma S, Nalband H, Sangapillai R, Sivashanmuganathan S, Pusalkar R, Anandan S, Masand G, Pratapreddy K, Harinarayana Rao S, Gokhale A, Vidyadhar Reddy GEC, Karanam G, Phatarphekar A, Rao P, Ramana V, Ramnath RL. Sathe N, et al. Among authors: ramana v. Vaccine. 2024 Feb 15;42(5):1051-1064. doi: 10.1016/j.vaccine.2023.10.006. Epub 2023 Oct 8. Vaccine. 2024. PMID: 37816655
29 results